+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radioactive Medical Isotopes Market - Global Forecast 2026-2032- Product Image
Radioactive Medical Isotopes Market - Global Forecast 2026-2032- Product Image
Sale

Radioactive Medical Isotopes Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6148750
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Radioactive Medical Isotopes Market is projected to reach USD 9.36 Billion in 2026. It is expected to continue growing at a CAGR of 10.75%, reaching USD 17.36 Billion by 2032.

Radioactive Medical Isotopes: Executive Overview

Radioactive medical isotopes are essential to nuclear medicine, supporting diagnostic imaging, targeted radionuclide therapy, and selected laboratory applications. The field combines reactor- and accelerator-based production, radiochemical processing, specialized transport, clinical administration, and radioactive-waste management. Its development is shaped by patient demand, isotope half-lives, production reliability, regulatory controls, hospital infrastructure, and access to trained specialists.

Production Resilience and Clinical Innovation Are Reshaping the Field

The landscape is shifting from dependence on a limited number of production assets toward more diversified supply models, including research reactors, cyclotrons, accelerator technologies, and regional processing capacity. At the same time, theranostics is linking diagnostic imaging with isotope-enabled treatment selection and monitoring. Short half-lives continue to make scheduling, transport, quality assurance, and proximity to treatment centers especially important. Regulatory harmonization, secure logistics, waste handling, and investment in nuclear-medicine workforce capacity remain central to sustainable adoption.

Artificial Intelligence Improves Imaging, Operations, and Treatment Planning

Artificial intelligence is influencing radioactive medical isotope workflows through image reconstruction, lesion detection, segmentation, dosimetry support, treatment planning, and clinical-trial analysis. It can help reduce interpretation variability and improve the use of complex multimodal data, but performance depends on representative datasets, validated clinical protocols, explainability, cybersecurity, and human oversight. In production and logistics, AI may support demand coordination, predictive maintenance, scheduling, and quality monitoring; however, it does not remove the need for radiochemical expertise, regulatory review, or clinician accountability.

Regional Priorities Reflect Distinct Infrastructure and Access Conditions

North America emphasizes advanced theranostics, established nuclear-medicine networks, domestic production resilience, and regulatory coordination. Europe combines strong research capacity with cross-border logistics, aging infrastructure in some areas, and efforts to improve supply continuity across national systems. Asia-Pacific includes major production and clinical centers alongside rapidly expanding access needs, with Japan, China, South Korea, India, and Australia representing varied policy and infrastructure environments. Latin America is focused on expanding diagnostic and therapeutic access while addressing equipment, specialist, and distribution constraints. The Middle East is developing specialized clinical capacity and regional supply arrangements, particularly where national healthcare investment supports nuclear medicine. Africa faces uneven access to reactors, cyclotrons, imaging equipment, trained personnel, and reliable distribution, making hub-based services, workforce development, and international cooperation important priorities.

Regional Alliances Can Strengthen Isotope Security and Clinical Coordination

ASEAN cooperation can support shared training, coordinated procurement, and cross-border referral pathways despite differing levels of nuclear-medicine infrastructure. BRICS members have opportunities to deepen collaboration in reactor technology, radiochemistry, clinical research, and supply resilience. The European Union benefits from common scientific and regulatory mechanisms, although national healthcare systems and transport requirements still require coordination. G7 economies can advance production diversification, safety standards, and research partnerships. GCC states can use integrated healthcare planning and shared specialist capacity to develop regional services. NATO members may benefit from aligned resilience planning for critical medical supply chains while maintaining the civilian focus and regulatory safeguards required for medical isotope use.

Country Profiles Show Diverse Strengths, Constraints, and Policy Priorities

Australia contributes research, production, and clinical expertise while serving geographically dispersed populations. Brazil and Mexico are working to broaden access across large territories and strengthen domestic capabilities. Canada and the United States combine mature nuclear-medicine systems with ongoing attention to production security, workforce capacity, and equitable access. China, India, Japan, and South Korea have substantial scientific and industrial capabilities but face distinct requirements for regional coverage, regulation, and clinical integration. France, Germany, Italy, Spain, and the United Kingdom have advanced hospital and research networks, with priorities including coordinated supply, infrastructure renewal, and access to emerging therapies. Russia maintains scientific and production capabilities, while international constraints and logistics affect collaboration and availability. Across these countries, the practical determinants of patient access remain isotope availability, qualified staff, compliant facilities, reimbursement, and dependable transport.

Industry Leaders Should Build Resilience Around Patients, Platforms, and Partnerships

Leaders should diversify qualified production routes, establish contingency inventories where scientifically and regulatorily appropriate, and strengthen end-to-end visibility from isotope generation to clinical administration. They should prioritize validated theranostic workflows, invest in radiopharmacy and dosimetry training, and collaborate with hospitals to align production schedules with patient demand. Digital tools, including AI, should be introduced through controlled validation, transparent governance, cybersecurity safeguards, and continuous performance monitoring. Organizations should also engage regulators early, plan for radioactive-waste responsibilities, develop equitable referral and distribution models, and use cross-border partnerships to improve resilience without compromising safety or quality.

Methodology: Evidence-Based Synthesis of the Radioactive Medical Isotopes Ecosystem

This executive summary uses the defined market scope of radioactive medical isotopes and synthesizes established evidence categories relevant to the field: isotope production technologies, radiochemical processing, nuclear-medicine diagnosis and therapy, healthcare infrastructure, regulation, logistics, workforce requirements, and regional cooperation. Insights are organized across regions, multinational groups, and specified countries to distinguish shared structural themes from local conditions. The assessment intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific claims, and presents qualitative conclusions grounded in observable industry, clinical, technological, and policy factors.

Reliable Access and Clinical Integration Will Define Long-Term Progress

The radioactive medical isotopes field is advancing through the combined effects of theranostic medicine, diversified production, digital decision support, and stronger international coordination. Progress will depend less on any single technology than on the integration of safe supply chains, capable facilities, trained professionals, validated clinical pathways, and responsible data use. Stakeholders that connect production resilience with patient-centered delivery will be best positioned to expand the benefits of nuclear medicine while maintaining rigorous standards for safety, quality, and accountability.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Radioactive Medical Isotopes Market, by Radioisotope Type
7.1. Introduction
7.2. Diagnostic Radioisotopes
7.2.1. Technetium-99m (Tc-99m)
7.2.2. Fluorine-18 (F-18)
7.2.3. Iodine-123 (I-123)
7.2.4. Gallium-68 (Ga-68)
7.2.5. Rubidium-82 (Rb-82)
7.2.6. Thallium-201 (Tl-201)
7.3. Therapeutic Radioisotopes
7.3.1. Lutetium-177 (Lu-177)
7.3.2. Iodine-131 (I-131)
7.3.3. Yttrium-90 (Y-90)
7.3.4. Radium-223 (Ra-223)
7.3.5. Actinium-225 (Ac-225)
7.3.6. Lead-212 (Pb-212)
7.4. Theranostic Radioisotopes
7.4.1. Copper-64 (Cu-64)
7.4.2. Copper-67 (Cu-67)
8. Radioactive Medical Isotopes Market, by Radiation Type
8.1. Introduction
8.2. Alpha Emitters
8.3. Beta Emitters
8.4. Gamma Emitters
8.5. Positron Emitters
8.6. Auger Electron Emitters
9. Radioactive Medical Isotopes Market, by Production Technology
9.1. Introduction
9.2. Reactor-Based Isotopes
9.2.1. Neutron Activation
9.2.2. Fission-Produced Isotopes
9.3. Cyclotron-Based Isotopes
9.4. Linear Accelerator (LINAC) Produced
9.5. Radionuclide Generator Systems
10. Radioactive Medical Isotopes Market, by Application
10.1. Introduction
10.2. Diagnostic Imaging
10.2.1. PET Imaging
10.2.2. SPECT Imaging
10.2.3. Planar Scintigraphy
10.3. Therapeutic Applications
10.3.1. Targeted Radionuclide Therapy
10.3.2. Bone-Targeting Therapy
10.3.3. Radioiodine Therapy
10.3.4. Brachytherapy
10.3.5. Radioimmunotherapy
10.4. Medical Equipment Sterilization
10.5. Drug Development & Clinical Trials
10.6. Theranostics Applications
11. Radioactive Medical Isotopes Market, by Disease Indication
11.1. Introduction
11.2. Oncology
11.3. Cardiology
11.4. Neurology
11.5. Endocrinology
11.6. Urology
11.7. Pulmonology
11.8. Gastroenterology
11.9. Infectious Diseases
11.10. Hematology
12. Radioactive Medical Isotopes Market, by End-User
12.1. Introduction
12.2. Hospitals
12.3. Diagnostic Imaging Centers
12.4. Cancer Treatment Centers
12.5. Academic & Research Institutes
12.6. Pharmaceutical & Biotechnology Companies
12.7. Contract Development & Manufacturing Organizations (CDMOs)
13. Radioactive Medical Isotopes Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. Europe
13.4. North America
13.5. Latin America
13.6. Africa
13.7. Middle East
14. Radioactive Medical Isotopes Market, by Group
14.1. Introduction
14.2. NATO
14.3. G7
14.4. European Union
14.5. BRICS
14.6. ASEAN
14.7. GCC
15. Radioactive Medical Isotopes Market, by Country
15.1. Introduction
15.2. United States
15.3. China
15.4. Germany
15.5. Japan
15.6. India
15.7. United Kingdom
15.8. France
15.9. Canada
15.10. Australia
15.11. Italy
15.12. Brazil
15.13. Mexico
15.14. South Korea
15.15. Russia
15.16. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Curium Pharma Holding SAS
17.2. Eckert & Ziegler SE
17.3. ITM Isotope Technologies Munich SE
17.4. BWXT Medical Ltd.
17.5. Jubilant Pharma Limited
17.6. NorthStar Medical Radioisotopes, LLC
17.7. SHINE Technologies, LLC
17.8. SpectronRx, Inc.
17.9. ASP Isotopes Inc.
17.10. ABX advanced biochemical compounds GmbH
17.11. Actinium Pharmaceuticals, Inc.
17.12. Alpha Tau Medical Ltd.
17.13. ARTBIO, Inc.
17.14. Cardinal Health, Inc.
17.15. China Isotope & Radiation Corporation
17.16. Cyclotek Pty Ltd
17.17. GE HealthCare Technologies Inc.
17.18. Global Medical Solutions, Ltd.
17.19. Isotopia Molecular Imaging Ltd.
17.20. Nordion (Canada) Inc.
17.21. Novartis AG
17.22. NTP Radioisotopes SOC Ltd
17.23. Nusano, Inc.
17.24. Orano Med SAS
17.25. PanTera S.A.
17.26. Perspective Therapeutics, Inc.
17.27. Siemens Healthineers AG
17.28. SOFIE Biosciences, Inc.
17.29. Telix Pharmaceuticals Limited
17.30. TerraPower, LLC
17.31. Terumo Corporation
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Radioactive Medical Isotopes Market, Years Considered for the Study
FIGURE 2. Global Radioactive Medical Isotopes Market, Research Design
FIGURE 3. Global Radioactive Medical Isotopes Market, Research Framework
FIGURE 4. Global Radioactive Medical Isotopes Market, Data Triangulation
FIGURE 5. Global Radioactive Medical Isotopes Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2025 vs 2032 (%)
FIGURE 7. Global Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Radioactive Medical Isotopes Market Size, by Radiation Type, 2025 vs 2032 (%)
FIGURE 9. Global Radioactive Medical Isotopes Market Size, by Radiation Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Radioactive Medical Isotopes Market Size, by Production Technology, 2025 vs 2032 (%)
FIGURE 11. Global Radioactive Medical Isotopes Market Size, by Production Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Radioactive Medical Isotopes Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Radioactive Medical Isotopes Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Radioactive Medical Isotopes Market Size, by Disease Indication, 2025 vs 2032 (%)
FIGURE 15. Global Radioactive Medical Isotopes Market Size, by Disease Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Radioactive Medical Isotopes Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 17. Global Radioactive Medical Isotopes Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Radioactive Medical Isotopes Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Radioactive Medical Isotopes Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Radioactive Medical Isotopes Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Radioactive Medical Isotopes Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Radioactive Medical Isotopes Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Radioactive Medical Isotopes Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Radioactive Medical Isotopes Market Segmentation & Coverage
TABLE 2. Global Radioactive Medical Isotopes Market Size, 2017-2032 (USD Million)
TABLE 3. Global Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 4. Global Diagnostic Radioisotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Diagnostic Radioisotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Diagnostic Radioisotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Technetium-99m (Tc-99m) Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Technetium-99m (Tc-99m) Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Technetium-99m (Tc-99m) Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Fluorine-18 (F-18) Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Fluorine-18 (F-18) Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Fluorine-18 (F-18) Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Iodine-123 (I-123) Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Iodine-123 (I-123) Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Iodine-123 (I-123) Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Gallium-68 (Ga-68) Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Gallium-68 (Ga-68) Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Gallium-68 (Ga-68) Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Rubidium-82 (Rb-82) Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Rubidium-82 (Rb-82) Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Rubidium-82 (Rb-82) Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Thallium-201 (Tl-201) Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Thallium-201 (Tl-201) Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Thallium-201 (Tl-201) Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Therapeutic Radioisotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Therapeutic Radioisotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Therapeutic Radioisotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Lutetium-177 (Lu-177) Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Lutetium-177 (Lu-177) Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Lutetium-177 (Lu-177) Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Iodine-131 (I-131) Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Iodine-131 (I-131) Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Iodine-131 (I-131) Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Yttrium-90 (Y-90) Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Yttrium-90 (Y-90) Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Yttrium-90 (Y-90) Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Radium-223 (Ra-223) Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Radium-223 (Ra-223) Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Radium-223 (Ra-223) Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Actinium-225 (Ac-225) Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Actinium-225 (Ac-225) Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Actinium-225 (Ac-225) Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Lead-212 (Pb-212) Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Lead-212 (Pb-212) Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Lead-212 (Pb-212) Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Theranostic Radioisotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Theranostic Radioisotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Theranostic Radioisotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Copper-64 (Cu-64) Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Copper-64 (Cu-64) Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Copper-64 (Cu-64) Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Copper-67 (Cu-67) Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Copper-67 (Cu-67) Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Copper-67 (Cu-67) Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 56. Global Alpha Emitters Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Alpha Emitters Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Alpha Emitters Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Beta Emitters Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Beta Emitters Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Beta Emitters Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Gamma Emitters Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Gamma Emitters Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Gamma Emitters Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Positron Emitters Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Positron Emitters Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Positron Emitters Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Auger Electron Emitters Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Auger Electron Emitters Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Auger Electron Emitters Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 72. Global Reactor-Based Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Reactor-Based Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Reactor-Based Isotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Neutron Activation Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Neutron Activation Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Neutron Activation Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Fission-Produced Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Fission-Produced Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Fission-Produced Isotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Cyclotron-Based Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Cyclotron-Based Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Cyclotron-Based Isotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Linear Accelerator (LINAC) Produced Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Linear Accelerator (LINAC) Produced Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Linear Accelerator (LINAC) Produced Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Radionuclide Generator Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Radionuclide Generator Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Radionuclide Generator Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. Global Diagnostic Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Diagnostic Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Diagnostic Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global PET Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global PET Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global PET Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global SPECT Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global SPECT Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global SPECT Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Planar Scintigraphy Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Planar Scintigraphy Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Planar Scintigraphy Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Therapeutic Applications Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Therapeutic Applications Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Therapeutic Applications Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Targeted Radionuclide Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Targeted Radionuclide Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Targeted Radionuclide Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Bone-Targeting Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Bone-Targeting Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Bone-Targeting Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Radioiodine Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Radioiodine Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Radioiodine Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Brachytherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Brachytherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Brachytherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Radioimmunotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Radioimmunotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Radioimmunotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Medical Equipment Sterilization Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Medical Equipment Sterilization Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Medical Equipment Sterilization Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Drug Development & Clinical Trials Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Drug Development & Clinical Trials Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Drug Development & Clinical Trials Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Theranostics Applications Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Theranostics Applications Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Theranostics Applications Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 131. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Endocrinology Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Endocrinology Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Endocrinology Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Urology Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Urology Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Urology Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Pulmonology Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Pulmonology Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Pulmonology Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Gastroenterology Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Gastroenterology Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Gastroenterology Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Hematology Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Hematology Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Hematology Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 159. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. Global Cancer Treatment Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global Cancer Treatment Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global Cancer Treatment Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 172. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 174. Global Contract Development & Manufacturing Organizations (CDMOs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Global Contract Development & Manufacturing Organizations (CDMOs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. Global Contract Development & Manufacturing Organizations (CDMOs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 177. Global Radioactive Medical Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Asia-Pacific Radioactive Medical Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Asia-Pacific Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 180. Asia-Pacific Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 181. Asia-Pacific Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 182. Asia-Pacific Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 183. Asia-Pacific Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 184. Asia-Pacific Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 185. Asia-Pacific Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 186. Asia-Pacific Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Asia-Pacific Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 188. Asia-Pacific Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 189. Asia-Pacific Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 190. Asia-Pacific Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 191. Europe Radioactive Medical Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 192. Europe Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 193. Europe Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 194. Europe Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 195. Europe Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 196. Europe Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 197. Europe Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 198. Europe Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 199. Europe Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. Europe Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 201. Europe Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 202. Europe Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 203. Europe Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 204. North America Radioactive Medical Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 205. North America Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 206. North America Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 207. North America Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 208. North America Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 209. North America Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 210. North America Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 211. North America Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 212. North America Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. North America Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 214. North America Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 215. North America Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 216. North America Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 217. Latin America Radioactive Medical Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 218. Latin America Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 219. Latin America Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 220. Latin America Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 221. Latin America Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 222. Latin America Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 223. Latin America Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 224. Latin America Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 225. Latin America Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Latin America Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 227. Latin America Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 228. Latin America Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 229. Latin America Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 230. Africa Radioactive Medical Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 231. Africa Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 232. Africa Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 233. Africa Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 234. Africa Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 235. Africa Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 236. Africa Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 237. Africa Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 238. Africa Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. Africa Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 240. Africa Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 241. Africa Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 242. Africa Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 243. Middle East Radioactive Medical Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 244. Middle East Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 245. Middle East Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 246. Middle East Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 247. Middle East Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 248. Middle East Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 249. Middle East Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 250. Middle East Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 251. Middle East Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. Middle East Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 253. Middle East Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 254. Middle East Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 255. Middle East Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 256. Global Radioactive Medical Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 257. NATO Radioactive Medical Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 258. NATO Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 259. NATO Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 260. NATO Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 261. NATO Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 262. NATO Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 263. NATO Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 264. NATO Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 265. NATO Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. NATO Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 267. NATO Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 268. NATO Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 269. NATO Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 270. G7 Radioactive Medical Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 271. G7 Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 272. G7 Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 273. G7 Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 274. G7 Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 275. G7 Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 276. G7 Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 277. G7 Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 278. G7 Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. G7 Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 280. G7 Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 281. G7 Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 282. G7 Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 283. European Union Radioactive Medical Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 284. European Union Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 285. European Union Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 286. European Union Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 287. European Union Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 288. European Union Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 289. European Union Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 290. European Union Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 291. European Union Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. European Union Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 293. European Union Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 294. European Union Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 295. European Union Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 296. BRICS Radioactive Medical Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 297. BRICS Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 298. BRICS Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 299. BRICS Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 300. BRICS Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 301. BRICS Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 302. BRICS Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 303. BRICS Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 304. BRICS Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 305. BRICS Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 306. BRICS Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 307. BRICS Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 308. BRICS Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 309. ASEAN Radioactive Medical Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 310. ASEAN Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 311. ASEAN Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 312. ASEAN Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 313. ASEAN Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 314. ASEAN Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 315. ASEAN Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 316. ASEAN Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 317. ASEAN Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 318. ASEAN Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 319. ASEAN Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 320. ASEAN Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 321. ASEAN Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 322. GCC Radioactive Medical Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 323. GCC Radioactive Medical Isotopes Market Size, by Radioisotope Type, 2017-2032 (USD Million)
TABLE 324. GCC Radioactive Medical Isotopes Market Size, by Diagnostic Radioisotopes, 2017-2032 (USD Million)
TABLE 325. GCC Radioactive Medical Isotopes Market Size, by Therapeutic Radioisotopes, 2017-2032 (USD Million)
TABLE 326. GCC Radioactive Medical Isotopes Market Size, by Theranostic Radioisotopes, 2017-2032 (USD Million)
TABLE 327. GCC Radioactive Medical Isotopes Market Size, by Radiation Type, 2017-2032 (USD Million)
TABLE 328. GCC Radioactive Medical Isotopes Market Size, by Production Technology, 2017-2032 (USD Million)
TABLE 329. GCC Radioactive Medical Isotopes Market Size, by Reactor-Based Isotopes, 2017-2032 (USD Million)
TABLE 330. GCC Radioactive Medical Isotopes Market Size, by Application, 2017-2032 (USD Million)
TABLE 331. GCC Radioactive Medical Isotopes Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 332. GCC Radioactive Medical Isotopes Market Size, by Therapeutic Applications, 2017-2032 (USD Million)
TABLE 333. GCC Radioactive Medical Isotopes Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 334. GCC Radioactive Medical Isotopes Market Size, by End-User, 2017-2032 (USD Million)
TABLE 335. Global Radioactive Medical Isotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 336. United States Radioactive Medical Isotopes Market Size, 2017-2032 (USD Million)
TABLE 337. United States Radioactive Medical Isotopes Market Size, by Radioisot

Companies Mentioned

  • Curium Pharma Holding SAS
  • Eckert & Ziegler SE
  • ITM Isotope Technologies Munich SE
  • BWXT Medical Ltd.
  • Jubilant Pharma Limited
  • NorthStar Medical Radioisotopes, LLC
  • SHINE Technologies, LLC
  • SpectronRx, Inc.
  • ASP Isotopes Inc.
  • ABX advanced biochemical compounds GmbH
  • Actinium Pharmaceuticals, Inc.
  • Alpha Tau Medical Ltd.
  • ARTBIO, Inc.
  • Cardinal Health, Inc.
  • China Isotope & Radiation Corporation
  • Cyclotek Pty Ltd
  • GE HealthCare Technologies Inc.
  • Global Medical Solutions, Ltd.
  • Isotopia Molecular Imaging Ltd.
  • Nordion (Canada) Inc.
  • Novartis AG
  • NTP Radioisotopes SOC Ltd
  • Nusano, Inc.
  • Orano Med SAS
  • PanTera S.A.
  • Perspective Therapeutics, Inc.
  • Siemens Healthineers AG
  • SOFIE Biosciences, Inc.
  • Telix Pharmaceuticals Limited
  • TerraPower, LLC
  • Terumo Corporation

Related Topics

Related Reports

Iodine-131 Isotope Market - Global Forecast 2026-2032 - Product Image

Iodine-131 Isotope Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Alpha Emitters Market - Global Forecast 2026-2032 - Product Image

Alpha Emitters Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Nuclear Medicine (Radiopharmaceuticals) - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Nuclear Medicine (Radiopharmaceuticals) - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Radiopharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Radiopharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Radiopharmaceutical Supply Chain Market - Strategic Insights and Forecasts (2026-2031) - Product Image

Radiopharmaceutical Supply Chain Market - Strategic Insights and Forecasts (2026-2031)

  • Report
  • 156 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.